iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecime…
$0.79-2.97%
报价 2026-11-09
市值
$2M
EV
$-2.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -96.9%
$0.79$25.76
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ISPCiSpecimen Inc. | $2M | -3.0% | +204.8% | -29.6% | – | – | – | |
| SHPHShuttle Pharmaceuticals Holdings, Inc. | $24.7M | -7.1% | – | 0% | – | – | – | |
| BIAFbioAffinity Technologies, Inc. | $14.2M | -16.8% | +19.7% | -39.6% | – | – | – | |
| HSCSHeartSciences Inc. | $13.5M | -4.2% | +200.0% | -2,908.8% | – | – | – | |
| BIVIBioVie Inc. | $11.1M | -2.3% | +2771.1% | 0% | – | – | – | |
| TOVXTheriva Biologics, Inc. | $7.5M | -2.0% | 0.0% | 92% | – | – | – | |
| NDRAENDRA Life Sciences Inc. | $7.3M | +2.3% | 0.0% | 0% | – | – | – | |
| BJDXBluejay Diagnostics, Inc. | $2.8M | +6.0% | +54.9% | 0% | – | – | – | |
| ZCMDZhongchao Inc. | $17,365 | +2.6% | – | 43.8% | – | – | 0.1x | |
| 同行中位数 | – | – | +37.3% | 0% | – | – | 0.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。